HCPLive Network


Medicaid-insured youth, particularly those in foster care and those diagnosed with attention-deficit/hyperactivity disorder, have considerable exposure to atypical antipsychotics, according to a study published in the April issue of the Journal of Child and Adolescent Psychopharmacology.
According to research published in the Proceedings of the National Academy of Sciences, patients who are sensitive to d-amphetamine have a decreased likelihood of developing ADHD or schizophrenia.
ADHD in childhood is associated with an increased likelihood of obesity and physical inactivity during adolescence, according to a study published in the Journal of the American Academy of Child & Adolescent Psychiatry
Children with attention-deficit/hyperactivity disorder not treated with stimulants have higher body mass index (BMI), while those treated with stimulants have lower BMI earlier in childhood and more rapid rebound to higher BMI in late adolescence, according to a study published online March 17 in Pediatrics.
Children receiving in-school computer attention training for attention-deficit/hyperactivity disorder have greater improvements with neurofeedback rather than cognitive training, according to research published online Feb. 17 in Pediatrics.
The risk of serious transport accidents is increased in patients with attention-deficit/hyperactivity disorder (ADHD), and ADHD medication may reduce this risk, at least in males, according to research published online Jan. 29 in JAMA Psychiatry.
ADHD Resources